Last updated on November 2007

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)


Brief description of study

Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.

Detailed Study Description

The study will consist of a 30 day screening/washout phase at the end of which qualified subjects will be assigned to alfuzosin 10 mg tablets once a day. Subjects will be treated for 90 days. The total duration of the study will be 120 days.

Clinical Study Identifier: NCT00256399

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Allen D Seftel, MD

University Hospitals of Cleveland
Cleveland, OH United States
  Connect »